Literature DB >> 8328598

Mortality differences between New York City municipal and voluntary hospitals, for selected conditions.

M F Shapiro1, R E Park, J Keesey, R H Brook.   

Abstract

To determine if mortality differences between municipal and voluntary hospitals in New York City persist after adjustment for computerized administrative data (age, sex, principal diagnosis, and secondary diagnosis), six conditions in those hospitals from 1984 through 1987 were studied. Unadjusted mortality was significantly higher in municipal hospitals for myocardial infarction, stroke, and head trauma, and lower for congestive heart failure and pneumonia. Adjustment using administrative data eliminated differences for myocardial infarction, congestive heart failure, and pneumonia, but not for stroke and head trauma. We conclude that adjustment using administrative data eliminates some but not all mortality differences between municipal and voluntary hospitals. Medical record review is needed to determine why these differences persist.

Entities:  

Mesh:

Year:  1993        PMID: 8328598      PMCID: PMC1694761          DOI: 10.2105/ajph.83.7.1024

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  3 in total

Review 1.  Using the Knowledge Base of Health Services Research to Redefine Health Care Systems.

Authors:  Robert H Brook; Mary E Vaiana
Journal:  J Gen Intern Med       Date:  2015-04-04       Impact factor: 5.128

2.  Pulmonary sarcoidosis: comparison of patients at a university and a municipal hospital.

Authors:  H Yeager; D L Rabin; S R Stein; M S Richardson; R Singh; M A Devine; M Freedman
Journal:  J Natl Med Assoc       Date:  1999-06       Impact factor: 1.798

3.  Referral selection bias in the Medicare hospital mortality prediction model: are centers of referral for Medicare beneficiaries necessarily centers of excellence?

Authors:  D J Ballard; S C Bryant; P C O'Brien; D W Smith; M B Pine; D A Cortese
Journal:  Health Serv Res       Date:  1994-02       Impact factor: 3.402

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.